The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

about

The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

Item

http://www.wikidata.org/entity/Q38928135

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

@en

type

Item

label

The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

@en

prefLabel

The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

@en

P1476

The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

@en

P2093

Andrew F Olshan

http://www.w3.org/2001/XMLSchema#string

Elizabeth T H Fontham

http://www.w3.org/2001/XMLSchema#string

James L Mohler

http://www.w3.org/2001/XMLSchema#string

Jeannette T Bensen

http://www.w3.org/2001/XMLSchema#string

Jianwen Cai

http://www.w3.org/2001/XMLSchema#string

Laura Farnan

http://www.w3.org/2001/XMLSchema#string

Laura H Hendrix

http://www.w3.org/2001/XMLSchema#string

Matthew E Nielsen

http://www.w3.org/2001/XMLSchema#string

Melissa A Troester

http://www.w3.org/2001/XMLSchema#string

P2860

Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).

Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study.

Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions

Testosterone, diabetes mellitus, and the metabolic syndrome.

P304

878-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23342

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Saira Khan

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28261834

http://www.w3.org/2001/XMLSchema#string

P932

5695861

http://www.w3.org/2001/XMLSchema#string